Left ventricular hypertrophy: an overlooked cardiovascular risk factor
- PMID: 20516249
- DOI: 10.3949/ccjm.77a.09158
Left ventricular hypertrophy: an overlooked cardiovascular risk factor
Abstract
Left ventricular hypertrophy (LVH) is common in hypertensive patients, and it increases the risk of myocardial infarction, stroke, and death. Recent evidence indicates it is a modifiable risk factor that is not entirely dependent on blood pressure control. The authors review its pathogenesis, diagnosis, and treatment.
Comment in
-
LVH and hypertension: is treating the pressure not enough?Cleve Clin J Med. 2010 Jun;77(6):344. doi: 10.3949/ccjm.77a.06001. Cleve Clin J Med. 2010. PMID: 20516242 No abstract available.
Similar articles
-
Left ventricular hypertrophy: a potent cardiovascular risk factor and its relationship to office and ambulatory blood pressure.Blood Press Monit. 1999;4 Suppl 1:S19-22. Blood Press Monit. 1999. PMID: 10822413 Review.
-
Left ventricular hypertrophy: how to influence an important risk factor in hypertension.J Hypertens Suppl. 1998 Jan;16(1):S53-8. J Hypertens Suppl. 1998. PMID: 9534098 Review.
-
[The effect of losartan versus atenolol on cardiovascular morbidity and mortality in patients with hypertension and ECG-verified left ventricular hypertrophy in the LIFE-study].Ugeskr Laeger. 2003 Jan 27;165(5):456-9. Ugeskr Laeger. 2003. PMID: 12599843 Clinical Trial. Danish.
-
Regression of left ventricular hypertrophy and cardiovascular risk changes in hypertensive patients.Ital Heart J. 2004 Jul;5(7):505-10. Ital Heart J. 2004. PMID: 15487267 Review.
-
[Left ventricular hypertrophy--an important, often unrecognized risk factor].Lakartidningen. 1998 Aug 5;95(32-33):3405-8. Lakartidningen. 1998. PMID: 9725954 Review. Swedish.
Cited by
-
Association between obesity and new-onset heart failure among patients with hypertension in Thailand.J Health Popul Nutr. 2024 Feb 29;43(1):33. doi: 10.1186/s41043-024-00530-6. J Health Popul Nutr. 2024. PMID: 38424593 Free PMC article.
-
Association between AT1 receptor gene polymorphism and left ventricular hypertrophy and arterial stiffness in essential hypertension patients: a prospective cohort study.BMC Cardiovasc Disord. 2022 Dec 28;22(1):571. doi: 10.1186/s12872-022-03024-7. BMC Cardiovasc Disord. 2022. PMID: 36577936 Free PMC article.
-
Assessment of subclinical cardiovascular alterations in nonfunctioning adrenal incidentalomas.Turk J Med Sci. 2022 Jun;52(3):677-682. doi: 10.55730/1300-0144.5360. Epub 2022 Jun 16. Turk J Med Sci. 2022. PMID: 36326332 Free PMC article.
-
Knockout of AMPKα2 Blocked the Protection of Sestrin2 Overexpression Against Cardiac Hypertrophy Induced by Pressure Overload.Front Pharmacol. 2021 Nov 17;12:716884. doi: 10.3389/fphar.2021.716884. eCollection 2021. Front Pharmacol. 2021. PMID: 34867324 Free PMC article.
-
Pharmacotherapy for hypertension-induced left ventricular hypertrophy.Cochrane Database Syst Rev. 2021 Oct 10;10(10):CD012039. doi: 10.1002/14651858.CD012039.pub3. Cochrane Database Syst Rev. 2021. PMID: 34628642 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources